Home » Topics » Briefs » Other news to note

Other news to note
RSS

La Jolla Pharmaceutical acquires rights to first-in-class galectin-3 inhibitor

Jan. 24, 2012

Capstone Therapeutics terminates development of two products

Jan. 23, 2012

Milestone developments for Novartis' Lucentis and Galvus in China

Jan. 19, 2012

Jazz Pharmaceuticals merges with Azur Pharma

Jan. 19, 2012

DARA BioSciences announces acquisitions

Jan. 18, 2012

Gilead Sciences completes acquisition

Jan. 18, 2012

Xenetic Biosciences updates status of SymbioTec acquisition and SIIL arrangements

Jan. 17, 2012

Omni Bio plans new clinical studies of alpha-1-antitrypsin

Jan. 17, 2012

Otsuka Pharmaceutical and UCB adjust focus of collaboration

Jan. 16, 2012

Alnylam provides update on pipeline goals for 2012

Jan. 13, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.